Sulfasalazine and Ankylosing Spondylitis
Authors: BERNARD AMOR
Journal: Annals of Internal Medicine (1984)

Letters and Corrections1 December 1984Sulfasalazine and Ankylosing SpondylitisBERNARD AMOR, M.D., ANDRÉ KAHAN, M.D., MAXIME DOUGADOS, M.D., FRANÇOIS DELRIEU, M.D.BERNARD AMOR, M.D.Search for more papers by this author, ANDRÉ KAHAN, M.D.Search for more papers by this author, MAXIME DOUGADOS, M.D.Search for more papers by this author, FRANÇOIS DELRIEU, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-101-6-878_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: We read with interest the review on sulfasalazine by Peppercorn (1). We write to suggest another indication for use of sulfasalazine.We have evaluated the therapeutic effect of sulfasalazine in the treatment of ankylosing spondylitis. Eight patients (mean age, 29 years; 5 male, 3 female) with classic ankylosing spondylitis and peripheral arthritis (2), whose active disease was not adequately controlled by non-steroidal anti-inflammatory drugs, were included in an open trial. Two patients had transient diarrhea but no roentgenographic or sigmoidoscopic evidence of ulcerative colitis or Crohn's disease. None of the patients had psoriasis or Reiter's...References1. PEPPERCORN M. Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med. 1984;101:377-86. LinkGoogle Scholar2. CALIN A. Ankylosing spondylitis. In: KELLEY WN, HARRIS ED, RUDDY S, SLEDGE CB, eds. Textbook of Rheumatology. Philadelphia: W.B. Saunders; 1981:1017-32. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: René Descartes University School of Medicine Hôspital Cochin Paris 14ème, France PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAnkylosing SpondylitisKunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trialAnkylosing SpondylitisSulfasalazine for the treatment of ankylosing spondylitis: Relic or niche medication?Ankylosing SpondylitisAnkylosing spondylitis and current disease-controlling agents: do they work?Therapeutic advances in ankylosing spondylitisRecent developments in the therapy of spondyloarthropathiesComparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study1 The spondylarthropathies: classification and diagnosis. Do we need new terminologies?Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of veterans affairs cooperative studySulfasalazine in the treatment of spondylarthropathyMANAGEMENT OF REFRACTORY ANKYLOSING SPONDYLITIS AND RELATED SPONDYLOARTHROPATHIESSecond-line treatment in seronegative spondylarthropathiesEvaluation of sulphasalazine in the treatment of spondyloarthropathies.Ankylosing spondylitisAre there any antirheumatic drugs that modify the course of ankylosing spondylitis?Sulphasalazine versus penicillamine in the treatment of rheumatoid arthritisPeriphere Arthritis 1 December 1984Volume 101, Issue 6Page: 878-878KeywordsAnkylosing spondylitisArthritisCrohn's diseaseDiarrheaDrugsPsoriasisUlcerative colitis Issue Published: 1 December 1984 PDF downloadLoading ...